000 01527 a2200457 4500
005 20250517091337.0
264 0 _c20160830
008 201608s 0 0 eng d
022 _a1791-7530
040 _aNLM
_beng
_cNLM
100 1 _aČapoun, Otakar
245 0 0 _aPrognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest® System for Detection of Circulating Tumor Cells.
_h[electronic resource]
260 _bAnticancer research
_cApr 2016
300 _a2019-26 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aDocetaxel
650 0 4 _aHumans
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplastic Cells, Circulating
650 0 4 _aPrognosis
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatic Neoplasms, Castration-Resistant
_xblood
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTaxoids
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aMikulová, Veronika
700 1 _aJančíková, Markéta
700 1 _aHonová, Hana
700 1 _aKološtová, Katarína
700 1 _aSobotka, Roman
700 1 _aMichael, Pešl
700 1 _aZima, Tomáš
700 1 _aHanuš, Tomáš
700 1 _aSoukup, Viktor
773 0 _tAnticancer research
_gvol. 36
_gno. 4
_gp. 2019-26
999 _c25916742
_d25916742